Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.
Oda K, Ikeda Y, Kashiyama T, Miyasaka A, Inaba K, Fukuda T, Asada K, Sone K, Wada-Hiraike O, Kawana K, Osuga Y, Fujii T.
Oda K, et al. Among authors: fujii t.
J Obstet Gynaecol Res. 2016 Jul;42(7):757-62. doi: 10.1111/jog.13018. Epub 2016 Apr 20.
J Obstet Gynaecol Res. 2016.
PMID: 27094348
Review.